Increased risk of cancer in patients with systemic lupus erythematosus
- PMID: 1586239
- PMCID: PMC1004687
- DOI: 10.1136/ard.51.4.437
Increased risk of cancer in patients with systemic lupus erythematosus
Abstract
To evaluate the risk of cancer in patients with systemic lupus erythematosus (SLE) a series of 205 consecutive patients (182 women and 23 men) were followed up for cancer through the files of the Finnish Cancer Registry. The follow up consisted of a total of 2340 person years. Fifteen cancers were diagnosed against 5.7 expected (relative risk (RR) 2.6, 95% confidence interval (CI) 1.5 to 4.4). Among the women there were four non-Hodgkin's lymphomas against 0.09 expected (RR 44, CI 11.9 to 111) and two soft tissue sarcomas against 0.04 expected (RR 49, CI 6.0 to 177). When evaluated by a case control study previous treatment with cytostatic drugs showed no influence on the occurrence of cancer in this series of patients with SLE.
Similar articles
-
Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.Scand J Rheumatol. 2018 Nov;47(6):461-464. doi: 10.1080/03009742.2017.1384054. Epub 2018 Jan 10. Scand J Rheumatol. 2018. PMID: 29318934
-
Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.Arthritis Rheum. 1997 Apr;40(4):761-8. doi: 10.1002/art.1780400424. Arthritis Rheum. 1997. PMID: 9125261
-
Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.Rheumatology (Oxford). 2000 Oct;39(10):1147-52. doi: 10.1093/rheumatology/39.10.1147. Rheumatology (Oxford). 2000. PMID: 11035137
-
Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.Ann Med. 2021 Dec;53(1):1687-1695. doi: 10.1080/07853890.2021.1981547. Ann Med. 2021. PMID: 34553648 Free PMC article.
-
Hodgkin's lymphoma in systemic lupus erythematosus.Rheumatology (Oxford). 2007 May;46(5):830-2. doi: 10.1093/rheumatology/kel444. Epub 2007 Jan 25. Rheumatology (Oxford). 2007. PMID: 17255135 Review.
Cited by
-
Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.Lupus. 2013 Aug;22(9):919-27. doi: 10.1177/0961203313497118. Epub 2013 Jul 15. Lupus. 2013. PMID: 23857987 Free PMC article.
-
Systemic lupus Erythematosus and IgA multiple myeloma: a rare association?Med Oncol. 2007;24(4):445-8. doi: 10.1007/s12032-007-0047-3. Med Oncol. 2007. PMID: 17917096
-
Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.Immunol Res. 2017 Apr;65(2):464-469. doi: 10.1007/s12026-016-8885-8. Immunol Res. 2017. PMID: 28091805
-
Systemic lupus erythematous and malignancy risk: a meta-analysis.PLoS One. 2015 Apr 17;10(4):e0122964. doi: 10.1371/journal.pone.0122964. eCollection 2015. PLoS One. 2015. PMID: 25885411 Free PMC article.
-
Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL).Clin Rheumatol. 2007 Sep;26(9):1491-4. doi: 10.1007/s10067-006-0532-7. Epub 2007 Feb 13. Clin Rheumatol. 2007. PMID: 17297594
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical